Lupin informs about unaudited financial results

12 Feb 2025 Evaluate

Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that the Board of Directors of the Company, at its meeting held on Tuesday, February 11, 2025, unanimously approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024. The abovesaid Unaudited Financial Results along with the Limited Review Reports of the Statutory Auditors thereon are enclosed. The Board meeting commenced on February 11, 2025, at 09:00 pm (IST) and concluded on February 12, 2025, at 12:10 am (IST).

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×